Tweet
<img alt="" height="1" width="1" />
Amgen seeks additional US denosumab approval
Reuters
NEW YORK, May 14 (Reuters) - Amgen Inc (AMGN.O) said it is seeking US approval of its closely-watched osteoporosis drug denosumab for reduction of fractures and other skeletal related events in patients with advanced cancer, marking its second US ...
Amgen Asks FDA To Approve Bone-Drug Denosumab For CancerWall Street Journal
Amgen seeks cancer approval for bone loss drugBusinessWeek
Market Report -- In Play (AMGN)MSN Money
Stock Markets Review -PR Newswire (press release)
all 77 news articles »
More...